---
figid: PMC2728515__1471-2121-10-57-6
figlink: /pmc/articles/PMC2728515/figure/F6/
number: F6
caption: A. Interaction between RA and the ERK pathway during promoted neural specification.
  FGF receptor tyrosine kinase inhibitor SU5402 and MEK1/2 inhibitors PD184352 and
  PD0325901, respectively suppresses neural differentiation of ESCs. In RA-treated
  cultures, PD184352, PD0325901 and RARα-selective antagonist Ro 41-5253 could inhibit
  the neural specification of ESCs, while SU5402 shows weak neural inhibition effect.
  RA probably enhances ERK phosphorylation via MEK1/2 or its upstream but not in a
  manner that is dependent on FGF signaling, and activated ERK1/2 mediates phosphorylation
  of the MAPK sites of Smad1 (pSmad1MAPK), which inhibits the inhibitory function
  of the bone morphogenetic proteins (BMPs)-Smad1 pathway on neural differentiation.
  Blockade of RA signaling might affect the activation of the upstream of ERK1/2,
  which leads to failure of neural specification of ESCs even with the stimulation
  of FGF signaling. B. Possible roles of Wnt signaling in RA-promoted neural differentiation.
  RA promotes neural specification probably by up-regulating Sfrp2, which inhibits
  the Wnt-β-catenin anti-neural pathway. Upon adding LiCl or CHIR99021, which stimulates
  the β-catenin signaling and/or BMP signaling through inhibition of GSK3, the suppression
  effects on neural specification of β-catenin pathway can be passed down even with
  the stimuli of RA. RA also may promote neural differentiation by up-regulating RAR,
  which may decrease β-catenin/LEF/TCF mediated transactivation. There exists a possibility
  that RA may suppress the inhibition effects on neural differentiation of Wnt-β-catenin
  pathway by sequestration of β-catenin. pSmad1GSK3 indicates phosphorylation of the
  GSK3 sites of Smad1.
pmcid: PMC2728515
papertitle: All-trans retinoic acid promotes neural lineage entry by pluripotent embryonic
  stem cells via multiple pathways.
reftext: Jianfeng Lu, et al. BMC Cell Biol. 2009;10:57-57.
pmc_ranked_result_index: '39691'
pathway_score: 0.9163406
filename: 1471-2121-10-57-6.jpg
figtitle: All-trans retinoic acid promotes neural lineage entry by pluripotent embryonic
  stem cells via multiple pathways
year: '2009'
organisms: Homo sapiens
ndex: 4d01c99f-deb9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2728515__1471-2121-10-57-6.html
  '@type': Dataset
  description: A. Interaction between RA and the ERK pathway during promoted neural
    specification. FGF receptor tyrosine kinase inhibitor SU5402 and MEK1/2 inhibitors
    PD184352 and PD0325901, respectively suppresses neural differentiation of ESCs.
    In RA-treated cultures, PD184352, PD0325901 and RARα-selective antagonist Ro 41-5253
    could inhibit the neural specification of ESCs, while SU5402 shows weak neural
    inhibition effect. RA probably enhances ERK phosphorylation via MEK1/2 or its
    upstream but not in a manner that is dependent on FGF signaling, and activated
    ERK1/2 mediates phosphorylation of the MAPK sites of Smad1 (pSmad1MAPK), which
    inhibits the inhibitory function of the bone morphogenetic proteins (BMPs)-Smad1
    pathway on neural differentiation. Blockade of RA signaling might affect the activation
    of the upstream of ERK1/2, which leads to failure of neural specification of ESCs
    even with the stimulation of FGF signaling. B. Possible roles of Wnt signaling
    in RA-promoted neural differentiation. RA promotes neural specification probably
    by up-regulating Sfrp2, which inhibits the Wnt-β-catenin anti-neural pathway.
    Upon adding LiCl or CHIR99021, which stimulates the β-catenin signaling and/or
    BMP signaling through inhibition of GSK3, the suppression effects on neural specification
    of β-catenin pathway can be passed down even with the stimuli of RA. RA also may
    promote neural differentiation by up-regulating RAR, which may decrease β-catenin/LEF/TCF
    mediated transactivation. There exists a possibility that RA may suppress the
    inhibition effects on neural differentiation of Wnt-β-catenin pathway by sequestration
    of β-catenin. pSmad1GSK3 indicates phosphorylation of the GSK3 sites of Smad1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF8
  - RARB
  - RARA
  - FGF4
  - WNT4
  - FGF6
  - WNT6
  - FGF5
  - FGF7
  - WNT1
  - FGF2
  - WNT7A
  - WNT16
  - WNT5A
  - MAP2K1
  - FGF3
  - WNT3
  - WNT7B
  - FGF9
  - MAP2K2
  - GSK3B
  - SFRP2
  - CTNNB1
  - MAPK3
  - FGF12
  - WNT2
  - FGF14
  - WNT9B
  - GSK3A
  - WNT10A
  - WNT8B
  - WNT3A
  - WNT5B
  - WNT8A
  - FGF13
  - NRAS
  - FGF11
  - WNT11
  - RARG
  - WNT9A
  - FGF17
  - FGF19
  - FGF21
  - HRAS
  - FGF10
  - WNT10B
  - FGF16
  - WNT2B
  - FGF23
  - FGF18
  - FGF20
  - FGF22
  - KRAS
  - Ro 41-5253
  - PD 184352
  - Cancer
genes:
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: RAR
  symbol: RAR
  source: bioentities_symbol
  hgnc_symbol: RARB
  entrez: '5915'
- word: RAR
  symbol: RAR
  source: bioentities_symbol
  hgnc_symbol: RARA
  entrez: '5914'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Sfrp2
  symbol: SFRP2
  source: hgnc_symbol
  hgnc_symbol: SFRP2
  entrez: '6423'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: ERK1/2-pSmad1MAPK,
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: RAR
  symbol: RAR
  source: bioentities_symbol
  hgnc_symbol: RARG
  entrez: '5916'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: Wnts
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF/FGFreceptors
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals:
- word: Ro 41-5253
  source: MESH
  identifier: C084904
- word: PD 184352
  source: MESH
  identifier: C120227
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2728515__F6
redirect_from: /figures/PMC2728515__F6
figtype: Figure
---
